Pharma

Bill to allow imported drugs from Canada aims to create competition

Bill to allow imported drugs from Canada aims to create competition

By

The Congressional Budget Office says that Sanders' bill would save the U.S. federal government nearly $7 billion over the next decade.

Drugmakers test out Tumblr, to tap specific audiences

Drugmakers test out Tumblr, to tap specific audiences

By By

Pharma has more or less ignored the social-blog hybrid Tumblr, with the number of programs using it countable on a single hand. That's about to change.

Pharma companies, now marketing high-science drugs, rely more on medical affairs

Pharma companies, now marketing high-science drugs, rely more on medical affairs

By

Five years ago, the notion of medical science liaisons as a guiding voice in the marketing mix was borderline preposterous. Now they're called upon early and often.

On Shkreli, Here Are the Lessons for Pharma to Learn and Apply

On Shkreli, Here Are the Lessons for Pharma to Learn and Apply

Though Shkreli may soon slip from the public eye, separated from his Twitter account and prohibited from trading securities, pharma communicators must learn from these events.

From diversity to pricing issues, BMS marketing chief strikes a balance

From diversity to pricing issues, BMS marketing chief strikes a balance

By

Susan Sweeney has earned a reputation for such pragmatism and attentiveness to the things that really matter.

Neil Matheson leaves Huntsworth Health

Neil Matheson leaves Huntsworth Health

By

The CEO of Huntsworth's biggest and fastest-growing unit Huntsworth Health, which includes Nitrogen and Tonic Life, has departed after eight years.

WebMD sells to private equity firm KKR

WebMD sells to private equity firm KKR

By

The deal is worth roughly $2.8 billion.

Five things for pharma marketers to know: Wednesday, July 19, 2017

Five things for pharma marketers to know: Wednesday, July 19, 2017

By

Cost of throwing out expired drugs is $800 million per year; the FDA approves Gilead's new HCV drug; CDC says 1 in 10 Americans have diabetes

Hijacked by shampoo or an increasingly relevant place for PR to shine? Experts dissect Lions Health

Hijacked by shampoo or an increasingly relevant place for PR to shine? Experts dissect Lions Health

By

The relative dearth of Pharma entries, and the fact that Lions Health is very much a separate affair to the rest of the week are two factors for the Lions to keep an eye on.

MM&M's top 100 healthcare agencies of 2017

MM&M's top 100 healthcare agencies of 2017

Here, we profile 100 of the largest healthcare advertising agencies in North America.

Agencies embrace health, in bid to diversify beyond pharma

Agencies embrace health, in bid to diversify beyond pharma

By

Healthcare networks instigated a broad set of changes in a grand embrace of non-pharma business that diversified revenue streams and took specialist agencies out of their comfort zones.

Day 1 at Lions Health: Use the data, stay persistent, and avoid being 'innovative'

Day 1 at Lions Health: Use the data, stay persistent, and avoid being 'innovative'

If there is one thing to take away from the opening day at the Cannes Lions International Festival of Creativity, it is this. Find the talks that inspire you, and then find the places with AC.

Lions Health: The 2017 pharma winners

Lions Health: The 2017 pharma winners

A public health campaign developed by McCann Health India for children in Afghanistan was the big winner in 2017.

U.S. campaigns make up one-third of Lions Health pharma shortlist

U.S. campaigns make up one-third of Lions Health pharma shortlist

By

In the Lions Health pharma shortlist, released Saturday morning, five branded campaign made it through the judging process for the branded prescription categories.

Five things for pharma marketers to know: Wednesday, June 14, 2017

Five things for pharma marketers to know: Wednesday, June 14, 2017

By

Sanofi to boost investment in biologics R&D; Sage's awareness campaign criticized; PatientsLikeMe poll finds 95% of patients want some costs of drugs covered

Healthcare brands turn to emotion, to better tell their stories

Healthcare brands turn to emotion, to better tell their stories

By

It's never been easy for pharmaceutical companies or healthcare brands to authentically engage with patients or with doctors.

Why Novartis' Shah-Mehta chose a career in pharma sales

Why Novartis' Shah-Mehta chose a career in pharma sales

By

The executive director of oncology marketing is fascinated by the resilience of the human body.

Five things for pharma marketers to know: Friday, June 2, 2017

Five things for pharma marketers to know: Friday, June 2, 2017

By

Oncologists more likely to prescribe drugs when receiving travel, meal payments; Tesaro reportedly considering a sale; AbbVie has best pharma reputation

Keep Calm and Sell Drugs: Your New Daily Affirmation?

Keep Calm and Sell Drugs: Your New Daily Affirmation?

By

To be sure, anything borrowing from the well-known "Keep Calm" genre should not be construed as advice. The doctor is definitely not in.

Five things for pharma marketers to know: Tuesday, May 30, 2017

Five things for pharma marketers to know: Tuesday, May 30, 2017

By

Harvard Pilgrim signs two outcomes contracts with AstraZeneca; lobbyists fight over drug-pricing proposals; docs say no to adult ADHD screening test

Pricing pressure is the new new normal for drugmakers

Pricing pressure is the new new normal for drugmakers

By By

Drug prices, as you may have heard, are kind of high. But price growth has slowed after sharp spikes in 2014 and 2015.

Gilead Sciences | 2017

By

Hepatitis C is so 2015 — at least, that's what Gilead Sciences CEO John Milligan is saying following his first year at the helm.

Pfizer | 2017

By

Is Pfizer finally in a position to close the Lipitor chapter, the one titled "how to bounce back from monumental loss"? All signs indicate yes.

Johnson & Johnson | 2017

By

After mulling over M&A options, Johnson & Johnson sprang into action in pursuit of Swiss biotech Actelion and initially received muted applause from investors.

Merck | 2017

By

The Kenilworth, New Jersey, company expects 2017 to produce the same worldwide sales scenario as last year. Yet despite the cautious outlook, stock prices are hovering higher than they were at this time in 2016.

Amgen | 2017

By

Biotech major Amgen is making good on a lofty promise to generate $1.5 billion in savings by 2018.

Teva Pharmaceutical Industries | 2017

By

The 2016 headliner for Teva Pharmaceutical Industries was its acquisition of Actavis Generics, which sent $33.43 billion in cash and about 100 million Teva shares to Allergan.

AbbVie | 2017

By

Any conversation about AbbVie has to begin with Humira, the best-selling drug in the world and the drugmaker's most important product.

Sanofi | 2017

By

Sanofi has been browsing in the acquisition aisle for some time now, even wheeling a few companies to the register only to leave empty-handed.

Roche | 2017

By

The FDA made patients, providers, and investors very happy when it approved Roche's Ocrevus in March.